Sexual Health

PrEP and PEP: Prevention of HIV Topical Map

Complete topic cluster & semantic SEO content plan — 32 articles, 5 content groups  · 

Build a definitive resource that covers clinical science, practical access, adherence and risk-reduction, and special-population guidance for PrEP and PEP. The strategy is to create deep pillar articles for each sub-theme supported by focused cluster pages (protocols, assistance programs, side-effect management, legal/consent issues, and scenario-specific guidance) so the site becomes the authoritative destination for both patients and clinicians.

32 Total Articles
5 Content Groups
20 High Priority
~6 months Est. Timeline

This is a free topical map for PrEP and PEP: Prevention of HIV. A topical map is a complete topic cluster and semantic SEO strategy that shows every article a site needs to publish to achieve topical authority on a subject in Google. This map contains 32 article titles organised into 5 topic clusters, each with a pillar page and supporting cluster articles — prioritised by search impact and mapped to exact target queries.

How to use this topical map for PrEP and PEP: Prevention of HIV: Start with the pillar page, then publish the 20 high-priority cluster articles in writing order. Each of the 5 topic clusters covers a distinct angle of PrEP and PEP: Prevention of HIV — together they give Google complete hub-and-spoke coverage of the subject, which is the foundation of topical authority and sustained organic rankings.

Strategy Overview

Build a definitive resource that covers clinical science, practical access, adherence and risk-reduction, and special-population guidance for PrEP and PEP. The strategy is to create deep pillar articles for each sub-theme supported by focused cluster pages (protocols, assistance programs, side-effect management, legal/consent issues, and scenario-specific guidance) so the site becomes the authoritative destination for both patients and clinicians.

Search Intent Breakdown

32
Informational

👤 Who This Is For

Intermediate

Clinics, sexual health publishers, public health NGOs, telehealth startups, and experienced health bloggers aiming to build a comprehensive HIV prevention resource for both patients and clinicians.

Goal: Within 12 months rank for core transactional and informational queries (e.g., 'how to get PrEP near me', 'PEP after exposure'), drive clinic referrals/telehealth leads, and become an authoritative resource cited by regional health services and community organizations.

First rankings: 3-6 months

💰 Monetization

High Potential

Est. RPM: $8-$25

Lead generation and referrals for telehealth/PrEP clinics and STI testing services Sponsored content and partnerships with sexual health clinics, public health agencies, or patient assistance programs Affiliate/referral fees for home testing kits, telemedicine subscriptions, or provider directories Ad revenue from targeted health advertisers and continuing medical education (CME) course promotions Grants and institutional sponsorships for public-health education content

Best monetization mixes clinical lead-gen (telehealth referrals, local clinic partnerships) with sponsored public-health content and grants; direct-to-consumer ad revenue supplements but is secondary due to medical trust requirements.

What Most Sites Miss

Content gaps your competitors haven't covered — where you can rank faster.

  • Localized, step-by-step guides to access PrEP/PEP by country, state, or province (including exact clinic lists, telehealth options, and lab logistics) — most sites remain generic.
  • Practical navigation of insurance, manufacturer assistance, and patient assistance programs with downloadable checklists and sample paperwork for uninsured or underinsured patients.
  • Detailed PEP-to-PrEP transition protocols, including timing of tests, drug interactions, and how to manage incomplete PEP adherence before starting PrEP.
  • Scenario-specific guidance for populations with unique needs: pregnancy and conception in serodiscordant couples, transgender individuals (hormone interactions), adolescents (consent/confidentiality), and people who inject drugs.
  • Operational implementation content for clinicians and clinics: workflow templates, lab-order sets, billing codes, standing orders, and population-level PrEP scale-up playbooks.
  • Long-term safety and monitoring deep dives — bone health, renal monitoring thresholds, switching algorithms between TDF, TAF, and injectable cabotegravir, and pregnancy considerations.
  • Behavioral adherence interventions and real-world case studies: digital adherence tools, community-based peer support programs, and metrics that move adherence, not just pill counts.
  • Legal/ethical content often missing: consent/guardian issues for minors, confidentiality in electronic records, partner notification nuances, and workplace/discrimination protections related to PrEP use.

Key Entities & Concepts

Google associates these entities with PrEP and PEP: Prevention of HIV. Covering them in your content signals topical depth.

PrEP PEP Truvada Descovy tenofovir emtricitabine CDC WHO UNAIDS sexual health clinics telemedicine PrEP services

Key Facts for Content Creators

Daily oral TDF/FTC PrEP reduces HIV acquisition risk by more than 90% with high adherence for receptive anal sex.

Highlighting efficacy signals the clinical value of PrEP content and supports pages on adherence strategies and evidence summaries.

PEP must be initiated within 72 hours of exposure and is prescribed as a 28-day antiretroviral course with scheduled testing.

This urgent-timeline stat supports content that needs clear CTAs and local access pathways for emergency care and telehealth.

Global new HIV infections were roughly 1.5 million in 2021 (UNAIDS), underscoring prevention needs.

Use global burden figures to justify public-health oriented content, grant-focused resources, and country-specific access guides.

In many high-income settings only about 20–30% of people clinically indicated for PrEP are receiving it, with substantial racial and geographic disparities.

This coverage gap supports content focused on equity, navigation of assistance programs, and outreach strategies to underserved populations.

Long-acting injectable cabotegravir (Apretude) was approved for HIV PrEP and offers dosing every two months after initiation.

Regulatory and product updates are search drivers; coverage comparisons (oral vs injectable) and clinic implementation guides are high-value content.

Common Questions About PrEP and PEP: Prevention of HIV

Questions bloggers and content creators ask before starting this topical map.

What are PrEP and PEP and how do they differ? +

PrEP (pre-exposure prophylaxis) is a medication taken before potential exposure to prevent HIV infection, while PEP (post-exposure prophylaxis) is an emergency treatment started after a potential exposure. PrEP is ongoing prevention for people at risk; PEP is a 28-day emergency course that must begin within 72 hours of exposure.

How effective is daily oral PrEP at preventing HIV? +

When taken consistently as prescribed, daily oral PrEP (tenofovir/emtricitabine) reduces the risk of acquiring HIV by more than 90% for receptive anal sex and substantially for other exposures; effectiveness falls if adherence is poor. Regular testing and follow-up are required to maintain protection and detect any infection early.

How soon must I start PEP after a possible HIV exposure? +

PEP must be started as soon as possible and no later than 72 hours after a known or suspected exposure to HIV; the sooner it's started the better. The standard PEP course lasts 28 days and includes baseline and follow-up HIV testing and safety monitoring.

Who should be offered PrEP? +

PrEP should be offered to people at substantial ongoing risk of HIV — for example, cis or trans men who have sex with men with recent condomless sex, people with HIV-positive partners not durably suppressed, people who inject drugs, or those with recent bacterial STIs. Eligibility is clinical and behavioral; a provider visit with baseline HIV testing and kidney function assessment is required.

How do I get PrEP if I don't have a local sexual health clinic? +

You can access PrEP via primary care, sexual health clinics, specialized telehealth programs, or community health organizations; many telemedicine providers offer online assessment, labs, and home delivery. Check for manufacturer assistance programs, state PrEP programs, or NGO resources that cover lab costs and medication for uninsured patients.

What routine monitoring is required while on PrEP? +

Standard monitoring includes HIV testing every 3 months, creatinine (renal) function at baseline and at least every 3–6 months for tenofovir-containing regimens, and STI screening every 3 months based on risk. Vaccination for hepatitis B and counseling about adherence and risk-reduction are also part of routine care.

Can PrEP cause kidney or bone problems, and how are these managed? +

Tenofovir disoproxil fumarate (TDF) can cause small declines in renal function and decrease bone mineral density in some people; these risks are monitored with baseline and periodic creatinine checks and risk assessment. For patients with renal concerns, tenofovir alafenamide (TAF) where indicated or injectable cabotegravir may be alternatives, and switching regimens or closer monitoring may be recommended.

Is injectable cabotegravir a better option than oral PrEP? +

Long-acting intramuscular cabotegravir (given every two months after initiation) is an approved option and demonstrated higher protection than daily oral TDF/FTC in key clinical trials for some populations. Choice depends on patient preference, access, cost/insurance coverage, and clinical factors like pregnancy plans or interactions with other medications.

Can adolescents use PrEP and what about consent laws? +

Adolescents at risk of HIV can be clinically eligible for PrEP; safety and dosing data support use in adolescents meeting weight and maturity criteria. Consent laws vary by jurisdiction — some areas allow minors to consent for sexual health services including PrEP without parental approval, so local legal guidance and confidentiality pathways are important.

Do I need to stop hormonal contraception or other meds while on PrEP? +

Most hormonal contraceptives and common medications do not interact with TDF/FTC-based PrEP, and PrEP does not reduce contraceptive effectiveness. However, some drug–drug interactions can occur with ART or other systemic medications; always review current medications with a clinician before starting PrEP.

How long should someone stay on PrEP and when is it safe to stop? +

People should remain on PrEP as long as they have ongoing risk for HIV exposure; stopping is reasonable when risk factors are resolved (e.g., a monogamous relationship with an HIV-negative partner or partner with durable viral suppression). After stopping PrEP for those using long-acting cabotegravir, follow specific clinical guidance on washout and testing; for oral PrEP some people use event-driven dosing for certain populations under clinician guidance.

What is the PEP-to-PrEP transition and when is it done? +

After completing a 28-day PEP course, individuals with ongoing risk should transition to PrEP; clinicians typically confirm negative HIV tests at completion of PEP and then start PrEP immediately. This prevents gaps in protection for people who continue to be exposed to HIV.

Why Build Topical Authority on PrEP and PEP: Prevention of HIV?

Building topical authority on PrEP and PEP positions a site at the intersection of preventive medicine, public health, and patient navigation — a high-traffic, high-impact niche with substantial clinical and commercial value. Dominance requires deep, locally actionable resources (access pathways, payer navigation, clinician implementation), which creates durable referral traffic, partnership opportunities with health services, and high trust signals that search engines and clinicians prioritize.

Seasonal pattern: Year-round with small peaks around Pride month (June), World AIDS Day (December 1), and back-to-school months for youth-focused outreach (August–September); evergreen clinical demand otherwise.

Content Strategy for PrEP and PEP: Prevention of HIV

The recommended SEO content strategy for PrEP and PEP: Prevention of HIV is the hub-and-spoke topical map model: one comprehensive pillar page on PrEP and PEP: Prevention of HIV, supported by 27 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on PrEP and PEP: Prevention of HIV — and tells it exactly which article is the definitive resource.

32

Articles in plan

5

Content groups

20

High-priority articles

~6 months

Est. time to authority

Content Gaps in PrEP and PEP: Prevention of HIV Most Sites Miss

These angles are underserved in existing PrEP and PEP: Prevention of HIV content — publish these first to rank faster and differentiate your site.

  • Localized, step-by-step guides to access PrEP/PEP by country, state, or province (including exact clinic lists, telehealth options, and lab logistics) — most sites remain generic.
  • Practical navigation of insurance, manufacturer assistance, and patient assistance programs with downloadable checklists and sample paperwork for uninsured or underinsured patients.
  • Detailed PEP-to-PrEP transition protocols, including timing of tests, drug interactions, and how to manage incomplete PEP adherence before starting PrEP.
  • Scenario-specific guidance for populations with unique needs: pregnancy and conception in serodiscordant couples, transgender individuals (hormone interactions), adolescents (consent/confidentiality), and people who inject drugs.
  • Operational implementation content for clinicians and clinics: workflow templates, lab-order sets, billing codes, standing orders, and population-level PrEP scale-up playbooks.
  • Long-term safety and monitoring deep dives — bone health, renal monitoring thresholds, switching algorithms between TDF, TAF, and injectable cabotegravir, and pregnancy considerations.
  • Behavioral adherence interventions and real-world case studies: digital adherence tools, community-based peer support programs, and metrics that move adherence, not just pill counts.
  • Legal/ethical content often missing: consent/guardian issues for minors, confidentiality in electronic records, partner notification nuances, and workplace/discrimination protections related to PrEP use.

What to Write About PrEP and PEP: Prevention of HIV: Complete Article Index

Every blog post idea and article title in this PrEP and PEP: Prevention of HIV topical map — 81+ articles covering every angle for complete topical authority. Use this as your PrEP and PEP: Prevention of HIV content plan: write in the order shown, starting with the pillar page.

Informational Articles

  1. What Are PrEP and PEP? Clear Definitions and Key Differences
  2. How PrEP Works: The Pharmacology Behind HIV Prevention
  3. How PEP Works: Timing, Mechanism, and Why Speed Matters
  4. History of HIV Prevention: The Development of PrEP and PEP
  5. Common Side Effects of PrEP and PEP: What To Expect and When To Seek Care
  6. Drug Interactions With PrEP and PEP: What Clinicians and Patients Must Know
  7. How Long Does PrEP Protect You? Onset, Duration, and Gaps in Coverage
  8. Cost and Insurance Basics for PrEP and PEP: Out-Of-Pocket, Assistance, and Formularies
  9. PrEP and PEP Myths Versus Facts: Correcting Common Misconceptions

Treatment / Solution Articles

  1. Initiating Daily Oral PrEP: A Clinician's Step-by-Step Protocol
  2. On-Demand (Event-Driven) PrEP: Dosing Guide, Evidence, and Practical Use Cases
  3. Emergency PEP Regimen: 72-Hour Window, Drug Choices, and Follow-Up Plan
  4. Switching From Oral PrEP To Long-Acting Cabotegravir: Indications And Transition Plan
  5. Managing PrEP-Related Renal Function Changes: Monitoring and Dose Adjustment
  6. PrEP During Pregnancy and Breastfeeding: Risks, Benefits, and Clinical Recommendations
  7. Managing Side Effects to Maintain PrEP Adherence: Clinical Strategies and Patient Scripts
  8. PrEP and Hepatitis B: Screening, Vaccination, and Co-Management Protocols
  9. Occupational PEP for Healthcare Workers: Institutional Protocols and Legal Considerations

Comparison Articles

  1. Daily Oral PrEP Versus Long-Acting Injectable PrEP: Efficacy, Side Effects, and Real-World Use
  2. TDF/FTC Versus TAF/FTC for PrEP: Safety, Efficacy, And Renal/Bone Considerations
  3. PrEP Versus Condoms: Complementary Strategies and When to Use Each
  4. On-Demand PrEP Versus Daily PrEP: Who Benefits Most From Each Approach
  5. PEP Regimens Compared: Integrase Inhibitor Versus Protease Inhibitor–Based Options
  6. Brand Versus Generic PrEP Drugs: Cost, Bioequivalence, And Patient Access
  7. PrEP Guidelines Compared: CDC, WHO, EACS, And National Variations Summarized
  8. PrEP Versus PEP for Travelers: Which Prevention Strategy Works for Short-Term Risk?
  9. Behavioral Interventions Versus Biomedical Interventions: Combining PrEP With Counseling

Audience-Specific Articles

  1. PrEP for Men Who Have Sex With Men (MSM): Risk Assessment, Dosing Options, And Outreach Strategies
  2. PrEP Guidance for Trans Women: Hormone Interactions, Access Barriers, And Clinical Best Practices
  3. PrEP for Cisgender Women: Effectiveness, Contraception Interactions, And Pregnancy Planning
  4. Adolescent PrEP: Consent Laws, Dosing, And Confidential Care Considerations
  5. PrEP for People Who Inject Drugs: Harm Reduction Integration and Prescribing Guidance
  6. PrEP for Serodiscordant Couples Trying To Conceive: Timing, ART, And Safety Protocols
  7. PrEP for Sex Workers: Outreach Strategies, Clinic Models, and Legal Barrier Navigation
  8. PrEP Considerations For Older Adults: Comorbidities, Polypharmacy, And Monitoring
  9. PrEP For Healthcare Workers: Postexposure Prophylaxis Options And Ongoing Prevention

Condition / Context-Specific Articles

  1. PrEP With Reduced Kidney Function: Adjustments, Alternatives, And Specialist Referral Criteria
  2. Managing PrEP in Patients With Hepatitis C Co-Infection: Screening And Treatment Coordination
  3. PEP After Sexual Assault: Trauma-Informed Clinical Workflow And Follow-Up Care
  4. PrEP and Mental Health Conditions: Assessing Adherence Risks and Integrated Care Pathways
  5. Using PrEP and PEP During International Travel: Pre-Trip Planning and On-Trip Access
  6. Chemsex and PrEP: Risk Reduction, Adherence Challenges, And Harm-Reduction Strategies
  7. PEP After Occupational Needlestick Injury: Stepwise Management and Employer Responsibilities
  8. PrEP Use in People With HIV Viral Suppression Partners: When Additional Prevention Is Appropriate
  9. PrEP For People Experiencing Homelessness: Clinic Models, Mobile Services, And Retention Strategies

Psychological / Emotional Articles

  1. Addressing Stigma Around PrEP: Communication Scripts For Clinicians And Advocates
  2. Supporting Adherence Motivation: Behavioral Techniques To Help Patients Stay On PrEP
  3. Counseling After A High-Risk Exposure: Emotional Triage And Clear Messaging For PEP Clients
  4. Navigating Partner Disclosure About PrEP: Strategies For Safety And Relationship Resilience
  5. Managing Fear Of Side Effects And Resistance: Reassurance, Education, And Decision Aids
  6. Trauma-Informed Care For Survivors Seeking PEP: Clinician Checklist And Language To Use
  7. Addressing Sexual Anxiety After Starting PrEP: Counseling Tips To Maintain Healthy Sexuality
  8. Building Peer Support Networks For PrEP Users: Models, Moderation, And Best Practices
  9. Addressing Provider Bias Toward PrEP Candidates: Training Modules And Reflective Practices

Practical / How-To Articles

  1. How To Start PrEP: Patient Checklist From First Visit To Maintenance
  2. How To Access Free Or Low-Cost PrEP: Navigating Assistance Programs And Manufacturer Coupons
  3. Telehealth PrEP Workflow: Virtual Initiation, Labs, And Follow-Up Templates For Clinics
  4. Laboratory Monitoring Schedule For PrEP: Baseline And Ongoing Tests With Interpretation Tips
  5. How To Apply For Insurance Coverage For PrEP: Authorization Letters And Coding Tips
  6. Clinic Start-Up Guide For A PrEP Program: Staffing, Metrics, And Patient Flow
  7. Adherence Tools And Reminders: Top Apps, Pillboxes, And Behavioral Nudges For PrEP Users
  8. How To Conduct Risk Assessment For PrEP Eligibility: Questions, Scoring, And Documentation
  9. Creating A PrEP Follow-Up Plan: Visit Frequency, Lab Reminders, And Retention Strategies

FAQ Articles

  1. How Fast Does PrEP Start Working? Timeline For Full Protection By Exposure Type
  2. Can You Use PEP As PrEP? Timing, Safety, And Clinical Recommendations
  3. What Happens If I Miss A PrEP Dose? Actions To Take And Risk Estimates
  4. Is PrEP Right For Me If My Partner Is Undetectable? U=U, Risk, And Shared Decision Making
  5. How Much Does PEP Cost Without Insurance? Emergency Options And Assistance Programs
  6. Can Adolescents Obtain PrEP Without Parental Consent? Laws By Jurisdiction And Practical Tips
  7. Will PrEP Affect My Fertility Or Pregnancy Outcome? Evidence Summary For Patients
  8. Can You Drink Alcohol While On PrEP Or PEP? Safety, Interactions, And Advice
  9. How Do I Know If PEP Worked? Timeline For Testing And Signs To Watch For

Research / News Articles

  1. 2024–2026 PrEP Landscape: Regulatory Approvals, Guideline Updates, And Global Implementation Trends
  2. Long-Acting Injectables For HIV Prevention: Latest Trial Results And Real-World Effectiveness
  3. Cabotegravir Versus Oral PrEP: Meta-Analysis Of Efficacy, Safety, And Subgroup Outcomes
  4. Real-World Adherence Studies For PrEP: What Implementation Data Tell Us About Uptake And Retention
  5. Emerging Prevention Technologies: bNAbs, Vaccines, And Novel Delivery Systems In 2026
  6. Cost-Effectiveness Of PrEP Strategies: From Individual-Level Use To National Scale-Up Models
  7. Global PrEP Access Inequities: Country Case Studies And Lessons For Scaling Equitable Programs
  8. New Resistance Data After PrEP/PEP Use: What The Latest Sequencing Studies Mean For Practice
  9. Policy Shifts Affecting PrEP Access: Insurance Mandates, Generic Launches, And Public Health Programs

This topical map is part of IBH's Content Intelligence Library — built from insights across 100,000+ articles published by 25,000+ authors on IndiBlogHub since 2017.

Find your next topical map.

Hundreds of free maps. Every niche. Every business type. Every location.